查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1803083

2032 年預防醫學市場預測：按服務類型、技術、交付模式、應用、最終用戶和地區進行的全球分析

Preventive Medicine Market Forecasts to 2032 - Global Analysis By Service Type, Technology, Mode of Delivery, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球預防醫學市場預計在 2025 年達到 4,515.9 億美元，到 2032 年將達到 9,258.2 億美元，預測期內的複合年成長率為 10.8%。

預防醫學是醫療保健領域的一部分，旨在透過預防疾病、傷害和殘疾來保護、促進和維護健康。預防性醫療保健包括改變生活方式、醫療干預、定期體檢和接種疫苗，以降低風險並及早發現潛在的健康問題。預防性醫療保健注重主動護理，能夠促進整體健康，最大限度地降低醫療成本，並在個人、社區和人口層面支持更健康的生活方式。

慢性病增多

心臟病、肥胖症和糖尿病等慢性疾病的流行刺激了預防性醫療保健的需求。由於許多此類疾病與生活方式選擇有關，早期療育被視為降低長期風險的可行解決方案。醫療保健系統和政策制定者正將重點轉向預防，以控制成本並改善整體健康。宣傳宣傳活動和公眾宣導活動鼓勵人們採取更健康的生活方式並定期進行體檢。科學研究不斷檢驗預防策略在降低發病率的有效性。因此，慢性病趨勢是預防性醫療保健產業擴張的主要催化劑。

缺乏經濟獎勵

由於醫療體系內部的經濟獎勵錯位，預防保健往往難以紮根。許多支付結構仍然優先治療而非預防，導致早期照護模式的投資對醫療服務提供者缺乏吸引力。醫生可能無法因提供預防服務而獲得報酬，這限制了他們融入常規醫療實踐。保險單通常不涵蓋健康計劃和篩檢，這限制了許多患者的就醫機會。長期儲蓄與短期經濟回報之間的這種脫節，在市場推廣中造成了阻力。如果不改變報銷和獎勵框架，預防保健將難以有效擴大規模。

與數位健康和​​人工智慧的融合

預防醫學與數位工具和人工智慧的融合，為個人化醫療開闢了新的途徑。健身追蹤器和健康應用程式等設備使用戶能夠即時監測自身健康狀況，從而促進主動健康管理。人工智慧演算法能夠分析數據，發現疾病的早期徵兆，並根據個人需求量身定做干涉措施。這些技術也使預防服務更具可擴展性和可近性，尤其是在醫療基礎設施有限的地區。隨著數位醫療的普及，它支持更聰明、更有效率的疾病預防方法。這些技術的協同作用正在重塑預防性醫療的提供和體驗方式。

資料隱私與網路安全風險

隨著預防性醫療保健越來越依賴數位平台，人們對資料安全和隱私的擔憂也日益凸顯。透過應用程式和遠端監控系統收集的健康資料容易受到駭客攻擊和未授權存取。現有法規往往落後於技術創新的步伐，導致用戶面臨潛在的濫用風險。敏感資訊的外洩會削弱信任，並減緩數位健康解決方案的普及。規模較小的供應商可能缺乏實施強大網路安全通訊協定的資源，從而增加其脆弱性。

COVID-19的影響：

由於醫療系統將資源重新用於疫情應對，新冠疫情的爆發暫時阻礙了預防醫學的發展。篩檢和體檢等非緊急服務被推遲，影響了早期診斷和介入工作。然而，這場危機凸顯了主動醫療管理和系統性韌性的價值。疫情期間遠端醫療的迅速普及，為遠距醫療服務開闢了新的途徑。隨著世界經濟復甦，這場疫情激發了以預防為導向的思維模式，並重新運作了市場投資和創新。

預計疫苗接種和疫苗接種服務部門將成為預測期內最大的部門

在社會日益關注疾病預防和加強全球衛生計畫的推動下，免疫接種和疫苗接種服務領域預計將在預測期內佔據最大的市場佔有率。 mRNA遞送、病毒載體系統和標靶免疫學等疫苗技術正在提高疫苗效力並縮短研發週期。個人化物流、人工智慧物流和免疫資訊學等趨勢正在重塑疫苗格局。近期的創新包括廣譜頻譜疫苗、先進的瘧疾和呼吸道合胞病毒（RSV）製劑以及改進的供應鏈基礎設施。政府支持和與數位平台的整合正在加速疫苗的普及，使疫苗成為現代預防醫學的基石。

預計家庭醫療保健領域在預測期內將實現最高複合年成長率

預計家庭醫療保健領域將在預測期內實現最高成長率，這得益於人口老化和慢性病發病率上升背景下對平價便捷醫療服務的需求不斷成長。智慧型穿戴裝置、虛擬諮詢和遠端監控工具等技術進步正在改善早期發現和持續支援。最近的進展包括人工智慧驅動的健康追蹤、方便用戶使用的行動平台以及無縫的數據整合。新興趨勢著重於客製化照護計畫、家庭看護者參與和基於結果的醫療保健。主動式居家照護的演變正在再形成預防性醫療保健，並將其範圍擴展到傳統臨床環境之外。

佔比最大的地區：

預計亞太地區將在預測期內佔據最大的市場佔有率，這得益於文明病的增加、人口結構變化以及公眾健康意識的不斷增強。基於人工智慧的診斷、穿戴式監測設備和數位健康平台等技術創新正在增強早期療育和個人化治療。最近的進展包括基於應用程式的健康追蹤、數據主導的風險評估和可擴展的預防性醫療保健模式。主要趨勢包括遠端醫療服務的擴展、雇主資助的健康計劃以及以結果為導向的醫療服務。政府的支持性政策和對醫療基礎設施不斷增加的投資，正在推動該地區朝著更預防性和以患者為中心的方向發展。

複合年成長率最高的地區：

在預測期內，由於人口老化、慢性病增多以及完善的醫療保健體系，北美預計將呈現最高的複合年成長率。智慧診斷、穿戴式健康監測器和人工智慧篩檢等先進技術正在增強早期療育和個人化治療。值得關注的發展包括雇主主導的舉措、基於結果的報銷模式以及預防保健保險覆蓋範圍的擴大。關鍵亮點包括遠端醫療、行動醫療解決方案和數據主導風險預測的興起。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球預防醫學市場（依服務類型）

  • 健康篩檢和風險評估
  • 免疫接種及疫苗接種服務
  • 生活方式和健康計劃
  • 基因檢測與個人化醫療
  • 數位預防解決方案
  • 其他服務類型

6. 全球預防醫學市場（依技術）

  • 早期檢測與篩檢技術
  • 遠端監控設備
  • 慢病管理平台
  • 預測分析和人工智慧工具

7. 全球預防醫學市場（依交付類型）

  • 現場服務
  • 遠端醫療和遠距護理服務
  • 行動醫療應用程式

8. 全球預防醫學市場（按應用）

  • 心血管疾病
  • 癌症
  • 糖尿病
  • 感染疾病
  • 呼吸系統疾病
  • 神經系統疾病
  • 其他用途

9. 全球預防醫學市場（依最終用戶）

  • 醫院和診所
  • 診斷中心
  • 企業和職場健康服務提供者
  • 家庭醫療保健
  • 政府和公共衛生機構
  • 其他最終用戶

第 10 章全球預防醫學市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Novo Nordisk
  • Medtronic plc
  • Eli Lilly and Company
  • Philips Healthcare
  • Quanterix Corporation
  • GE HealthCare
  • US Preventive Medicine, Inc.
  • Siemens Healthineers
  • Cancer Prevention Pharmaceuticals
  • Johnson & Johnson
  • Preventive Medical Health Care
  • Abbott Laboratories
  • Phoenix Medicine
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Sanofi
  • Merck & Co., Inc.
Product Code: SMRC30608

According to Stratistics MRC, the Global Preventive Medicine Market is accounted for $451.59 billion in 2025 and is expected to reach $925.82 billion by 2032 growing at a CAGR of 10.8% during the forecast period. Preventive medicine is a healthcare discipline dedicated to safeguarding, enhancing, and sustaining health by avoiding diseases, injuries, and disabilities before they arise. It includes lifestyle modifications, medical interventions, regular screenings, and immunizations to lower risks and identify potential health problems early. By focusing on proactive care, preventive medicine promotes overall well-being, minimizes healthcare expenses, and supports healthier lives at individual, community, and population scales.

Market Dynamics:

Driver:

Rising Incidence of Chronic Diseases

The growing prevalence of chronic illnesses like heart disease, obesity, and diabetes is fueling demand for preventive healthcare approaches. Since many of these conditions are linked to lifestyle choices, early intervention is increasingly seen as a practical solution to reduce long-term risks. Health systems and policymakers are shifting focus toward prevention to manage costs and improve overall well-being. Awareness campaigns and public education are encouraging individuals to adopt healthier habits and seek regular checkups. Scientific research continues to validate the effectiveness of preventive strategies in lowering disease rates. As a result, chronic disease trends are acting as a major catalyst for the expansion of the preventive medicine industry.

Restraint:

Lack of Aligned Financial Incentives

Preventive care often struggles to gain traction due to misaligned economic incentives within healthcare systems. Many payment structures still prioritize treatment over prevention, making it less attractive for providers to invest in early care models. Physicians may not be rewarded for offering preventive services, which limits their integration into routine practice. Insurance policies frequently exclude coverage for wellness programs and screenings, reducing access for many patients. This cut off between long-term savings and short-term financial returns creates friction in market adoption. Without changes to reimbursement and incentive frameworks, preventive medicine faces challenges in scaling effectively.

Opportunity:

Integration with Digital Health and AI

The fusion of preventive medicine with digital tools and artificial intelligence is opening new avenues for personalized healthcare. Devices like fitness trackers and health apps allow users to monitor their well-being in real time, promoting proactive health management. AI algorithms can analyze data to detect early signs of illness and tailor interventions to individual needs. These technologies also make preventive services more scalable and accessible, especially in areas with limited medical infrastructure. As digital health becomes more widespread, it supports smarter, more efficient approaches to disease prevention. This technological synergy is reshaping how preventive care is delivered and experienced.

Threat:

Data privacy and cybersecurity risks

As preventive medicine increasingly relies on digital platforms, concerns about data security and privacy are becoming more pronounced. Health data collected through apps and remote monitoring systems is susceptible to hacking and unauthorized access. Existing regulations often lag behind the pace of innovation, leaving users exposed to potential misuse. A breach of sensitive information can undermine trust and slow adoption of digital health solutions. Smaller providers may lack the resources to implement strong cybersecurity protocols, increasing vulnerability.

Covid-19 Impact:

The onset of COVID-19 temporarily stalled progress in preventive medicine, as healthcare systems redirected resources to manage the pandemic. Non-urgent services like screenings and wellness visits were delayed, affecting early diagnosis and intervention efforts. However, the crisis underscored the value of proactive health management and system resilience. The rapid adoption of telehealth during lockdowns created new pathways for delivering care remotely. As the world recovers, the pandemic has catalyzed a more prevention-oriented mindset, reinvigorating investment and innovation in the market.

The immunization & vaccination services segment is expected to be the largest during the forecast period

The immunization & vaccination services segment is expected to account for the largest market share during the forecast period, driven by increasing public focus on disease prevention and strengthened global health programs. Vaccine technologies such as mRNA delivery, viral vector systems, and targeted immunology are improving effectiveness and development timelines. Trends like customized immunization, AI-powered logistics, and immuno-informatics are reshaping the landscape. Recent innovations include broad-spectrum flu vaccines, advanced malaria and RSV formulations, and improved supply chain infrastructure. Support from governments and integration with digital platforms are accelerating uptake, positioning vaccines as a cornerstone of modern preventive medicine.

The home healthcare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate, due to increasing demand for affordable, accessible care amid growing elderly populations and chronic illness rates. Advancements in technology such as smart wearables, virtual consultations, and remote monitoring tools are improving early detection and continuous support. Recent progress includes AI-enabled health tracking, user-friendly mobile platforms, and seamless data integration. Emerging trends emphasize customized care plans, family caregiver engagement, and outcome-based healthcare. This evolution toward proactive, home-based services is reshaping preventive medicine and expanding its reach beyond traditional clinical environments.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by rising lifestyle-related illnesses, demographic shifts, and growing public health consciousness. Innovations in technology such as AI-driven diagnostics, wearable monitoring devices, and digital health platforms are enhancing early intervention and personalized treatment. Recent advancements include app-based wellness tracking, data-driven risk assessments, and scalable preventive care models. Key trends involve expanding telehealth services, employer-sponsored wellness programs, and outcome-focused healthcare delivery. Supportive government policies and increased investment in healthcare infrastructure are propelling the region toward a more preventive and patient-centric approach.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by an aging population, rising chronic conditions, and well-established healthcare systems. Advanced technologies such as smart diagnostics, wearable health monitors, and AI-enabled screening are enhancing early intervention and personalized treatment. Notable developments include employer-led wellness initiatives, outcome-based reimbursement models, and expanded insurance coverage for preventive care. Key trends highlight the rise of telemedicine, mobile health solutions, and data-driven risk prediction.

Key players in the market

Some of the key players in Preventive Medicine Market include Novo Nordisk, Medtronic plc, Eli Lilly and Company, Philips Healthcare, Quanterix Corporation, GE HealthCare, U.S. Preventive Medicine, Inc., Siemens Healthineers, Cancer Prevention Pharmaceuticals, Johnson & Johnson, Preventive Medical Health Care, Abbott Laboratories, Phoenix Medicine, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sanofi, and Merck & Co., Inc.

Key Developments:

In July 2025, Eli Lilly and Company announced the successful completion of its acquisition of Verve Therapeutics, Inc., Verve is a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease. This acquisition unlocks the opportunity to potentially transform the treatment paradigm for millions of patients worldwide by delivering lifelong cardiovascular risk reduction with a one-and-done treatment.

In May 2025, Septerna, Inc. and Novo Nordisk announced an exclusive global collaboration and license agreement to discover, develop and commercialise oral small molecule medicines for obesity, type 2 diabetes and other cardiometabolic diseases. The companies will initially commence four development programmes for potential small molecule therapies directed to one or more select G protein-coupled receptor (GPCR) targets, including the GLP-1, GIP and glucagon receptors.

In April 2025, Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump. Medtronic plc announced it has submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) seeking clearance for an interoperable pump. FDA clearance of this pump would pave the way for system integration with a continuous glucose monitoring (CGM) sensor based on Abbott's most advanced CGM platform.

Service Types Covered:

  • Health Screenings & Risk Assessments
  • Immunization & Vaccination Services
  • Lifestyle & Wellness Programs
  • Genetic Testing & Personalized Medicine
  • Digital Preventive Solutions
  • Other Service Types

Technologies Covered:

  • Early Detection & Screening Technologies
  • Remote Monitoring Devices
  • Chronic Disease Management Platforms
  • Predictive Analytics & AI Tools

Mode of Deliveries Covered:

  • In-Person Services
  • Telemedicine & Remote Care Services
  • Mobile Health Applications

Applications Covered:

  • Cardiovascular Diseases
  • Cancer
  • Diabetes
  • Infectious Diseases
  • Respiratory Diseases
  • Neurological Disorders
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Diagnostic Centers
  • Corporate & Workplace Wellness Providers
  • Home Healthcare
  • Government & Public Health Agencies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Preventive Medicine Market, By Service Type

  • 5.1 Introduction
  • 5.2 Health Screenings & Risk Assessments
  • 5.3 Immunization & Vaccination Services
  • 5.4 Lifestyle & Wellness Programs
  • 5.5 Genetic Testing & Personalized Medicine
  • 5.6 Digital Preventive Solutions
  • 5.7 Other Service Types

6 Global Preventive Medicine Market, By Technology

  • 6.1 Introduction
  • 6.2 Early Detection & Screening Technologies
  • 6.3 Remote Monitoring Devices
  • 6.4 Chronic Disease Management Platforms
  • 6.5 Predictive Analytics & AI Tools

7 Global Preventive Medicine Market, By Mode of Delivery

  • 7.1 Introduction
  • 7.2 In-Person Services
  • 7.3 Telemedicine & Remote Care Services
  • 7.4 Mobile Health Applications

8 Global Preventive Medicine Market, By Application

  • 8.1 Introduction
  • 8.2 Cardiovascular Diseases
  • 8.3 Cancer
  • 8.4 Diabetes
  • 8.5 Infectious Diseases
  • 8.6 Respiratory Diseases
  • 8.7 Neurological Disorders
  • 8.8 Other Applications

9 Global Preventive Medicine Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Diagnostic Centers
  • 9.4 Corporate & Workplace Wellness Providers
  • 9.5 Home Healthcare
  • 9.6 Government & Public Health Agencies
  • 9.7 Other End Users

10 Global Preventive Medicine Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Novo Nordisk
  • 12.2 Medtronic plc
  • 12.3 Eli Lilly and Company
  • 12.4 Philips Healthcare
  • 12.5 Quanterix Corporation
  • 12.6 GE HealthCare
  • 12.7 U.S. Preventive Medicine, Inc.
  • 12.8 Siemens Healthineers
  • 12.9 Cancer Prevention Pharmaceuticals
  • 12.10 Johnson & Johnson
  • 12.11 Preventive Medical Health Care
  • 12.12 Abbott Laboratories
  • 12.13 Phoenix Medicine
  • 12.14 F. Hoffmann-La Roche Ltd
  • 12.15 Pfizer Inc.
  • 12.16 Sanofi
  • 12.17 Merck & Co., Inc.

List of Tables

  • Table 1 Global Preventive Medicine Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Preventive Medicine Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 3 Global Preventive Medicine Market Outlook, By Health Screenings & Risk Assessments (2024-2032) ($MN)
  • Table 4 Global Preventive Medicine Market Outlook, By Immunization & Vaccination Services (2024-2032) ($MN)
  • Table 5 Global Preventive Medicine Market Outlook, By Lifestyle & Wellness Programs (2024-2032) ($MN)
  • Table 6 Global Preventive Medicine Market Outlook, By Genetic Testing & Personalized Medicine (2024-2032) ($MN)
  • Table 7 Global Preventive Medicine Market Outlook, By Digital Preventive Solutions (2024-2032) ($MN)
  • Table 8 Global Preventive Medicine Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 9 Global Preventive Medicine Market Outlook, By Technology (2024-2032) ($MN)
  • Table 10 Global Preventive Medicine Market Outlook, By Early Detection & Screening Technologies (2024-2032) ($MN)
  • Table 11 Global Preventive Medicine Market Outlook, By Remote Monitoring Devices (2024-2032) ($MN)
  • Table 12 Global Preventive Medicine Market Outlook, By Chronic Disease Management Platforms (2024-2032) ($MN)
  • Table 13 Global Preventive Medicine Market Outlook, By Predictive Analytics & AI Tools (2024-2032) ($MN)
  • Table 14 Global Preventive Medicine Market Outlook, By Mode of Delivery (2024-2032) ($MN)
  • Table 15 Global Preventive Medicine Market Outlook, By In-Person Services (2024-2032) ($MN)
  • Table 16 Global Preventive Medicine Market Outlook, By Telemedicine & Remote Care Services (2024-2032) ($MN)
  • Table 17 Global Preventive Medicine Market Outlook, By Mobile Health Applications (2024-2032) ($MN)
  • Table 18 Global Preventive Medicine Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Preventive Medicine Market Outlook, By Cardiovascular Diseases (2024-2032) ($MN)
  • Table 20 Global Preventive Medicine Market Outlook, By Cancer (2024-2032) ($MN)
  • Table 21 Global Preventive Medicine Market Outlook, By Diabetes (2024-2032) ($MN)
  • Table 22 Global Preventive Medicine Market Outlook, By Infectious Diseases (2024-2032) ($MN)
  • Table 23 Global Preventive Medicine Market Outlook, By Respiratory Diseases (2024-2032) ($MN)
  • Table 24 Global Preventive Medicine Market Outlook, By Neurological Disorders (2024-2032) ($MN)
  • Table 25 Global Preventive Medicine Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 26 Global Preventive Medicine Market Outlook, By End User (2024-2032) ($MN)
  • Table 27 Global Preventive Medicine Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 28 Global Preventive Medicine Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 29 Global Preventive Medicine Market Outlook, By Corporate & Workplace Wellness Providers (2024-2032) ($MN)
  • Table 30 Global Preventive Medicine Market Outlook, By Home Healthcare (2024-2032) ($MN)
  • Table 31 Global Preventive Medicine Market Outlook, By Government & Public Health Agencies (2024-2032) ($MN)
  • Table 32 Global Preventive Medicine Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.